31
https://pubmed.ncbi.nlm.nih.gov/38115179
KLK10’s overexpression in KRAS mutant colorectal cancer promotes disease progression and drug resistance via the PAR1-PDK1-AKT signaling pathway.
https://pubmed.ncbi.nlm.nih.gov/38115179
KLK10’s overexpression in KRAS mutant colorectal cancer promotes disease progression and drug resistance via the PAR1-PDK1-AKT signaling pathway.